Similar articles

• Improved prognosis in patients with acquired immunodeficiency syndrome-related lymphoma.

  Avilés A, Halabe J. Avilés A, et al. Cancer Biother Radiopharm. 1999 Oct;14(5):349-52. doi: 10.1089/cbr.1999.14.349. Cancer Biother Radiopharm. 1999. PMID: 10850319 Clinical Trial.
• Chemotherapy combined with zidovudine and GM-CSF in human immunodeficiency virus-related non-Hodgkin's lymphoma.

  Gabarre J, Lepage E, Thyss A, Tubiana R, Bastion Y, Schlaifer D, Sebban C, Ribrag V, Fereres M, Raphael M, et al. Gabarre J, et al. Ann Oncol. 1995 Dec;6(10):1025-32. doi: 10.1093/oxfordjournals.annonc.a059067. Ann Oncol. 1995. PMID: 8750156 Clinical Trial.
• Phase I trial of m-BACOD and granulocyte macrophage colony stimulating factor in HIV-associated non-Hodgkin's lymphoma.

  Walsh C, Wernz JC, Levine A, Rarick M, Willson E, Melendez D, Bonnem E, Thompson J, Shelton B. Walsh C, et al. J Acquir Immune Defic Syndr (1988). 1993 Mar;6(3):265-71. J Acquir Immune Defic Syndr (1988). 1993. PMID: 7680712 Clinical Trial.
• High dose intensity chemotherapy without bone marrow support: role of granulocyte-macrophage colony-stimulating factor.

  Venturini M, Del Mastro L, Ardizzoni A, Sertoli MR, Mariani GL, Pennucci MC, Garrone O, Silvestro S, Addamo GF, Queirolo P, et al. Venturini M, et al. Ann N Y Acad Sci. 1993 Nov 30;698:389-97. doi: 10.1111/j.1749-6632.1993.tb17231.x. Ann N Y Acad Sci. 1993. PMID: 8279779 Review. No abstract available.
• Intensive treatment of AIDS-related non-Hodgkin's lymphomas with the MACOP-B protocol.

  Schürmann D, Grünewald T, Weiss R, Jautzke G, Pohle HD, Ruf B. Schürmann D, et al. Eur J Haematol. 1995 Feb;54(2):73-7. doi: 10.1111/j.1600-0609.1995.tb01771.x. Eur J Haematol. 1995. PMID: 7535244 Review.